home / stock / mycof / mycof news

MYCOF News and Press, New Age Brands From 02/05/21

Stock Information
Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com
Menu
MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCOF - Mydecine Innovations Group Files Amended and Restated Financial Statements

Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO | OTC:MYCOF) (FSE: 0NFA) announces it has filed amended and restated unaudited condensed interim consolidated financial statements for the nine-month period ended September 30, 2020 (the “ Restated St...
MYCOF - Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

DENVER, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-s...

MYCOF - Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

DENVER, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstre...

MYCOF - Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

DENVER, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...
MYCOF - Psychedelic Updates: Mydecine, NeonMind, Ehave

Mydecine Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF)  has submitted a formal application to list its common shares on the NASDAQ Stock Exchange. NASDAQ is the second-largest exchange by market capitalization worldwide and is home to many of the world’s best...

MYCOF - Mydecine Innovations Group Files Application to list to the NASDAQ

DENVER, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-s...

MYCOF - Mydecine Innovations Group Included in First-Ever Psychedelics ETF

DENVER, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-s...
MYCOF - Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company co...

MYCOF - Mydecine Announces Change of Auditor

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), announces that the board of directors of the Company has appointed SHIM & Associates LLP, Chartered Professional Accountants as the Company’s new auditor...

MYCOF - KILL Mydecine Innovations Group Upsizes Previously Announced Bought Deal

Miller Thomson LLP requests that their press release NewsItemId: 20210120005543 “Mydecine Innovations Group Upsizes Previously Announced Bought Deal” be killed. The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations G...
Previous 10 Next 10